Unknown

Dataset Information

0

Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc degeneration.


ABSTRACT: Intervertebral disc degeneration (IVDD) can be caused by aging, injury, and genetic factors. The pathological changes associated with IVDD include the excessive accumulation of reactive oxygen species (ROS), cellular pyroptosis, and extracellular matrix (ECM) degradation. There are currently no approved specific molecular therapies for IVDD. In this study, we developed a multifunctional and microenvironment-responsive metal-phenolic network release platform, termed TMP@Alg-PBA/PVA, which could treat (IL-1β)-induced IVDD. The metal-phenolic network (TA-Mn-PVP, TMP) released from this platform targeted mitochondria to efficiently scavenge ROS and reduce ECM degradation. Pyroptosis was suppressed through the inhibition of the IL-17/ERK signaling pathway. These findings demonstrate the versatility of the platform. And in a rat model of IVDD, TMP@Alg-PBA/PVA exhibited excellent therapeutic effects by reducing the progression of the disease. TMP@Alg-PBA/PVA, therefore, presents clinical potential for the treatment of IVDD.

SUBMITTER: Zhou H 

PROVIDER: S-EPMC10954684 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc degeneration.

Zhou Hao H   He Jinpeng J   Liu Renfeng R   Cheng Jun J   Yuan Yuhao Y   Mao Wanpu W   Zhou Jun J   He Honghui H   Liu Qianqi Q   Tan Wei W   Shuai Cijun C   Deng Youwen Y  

Bioactive materials 20240315


Intervertebral disc degeneration (IVDD) can be caused by aging, injury, and genetic factors. The pathological changes associated with IVDD include the excessive accumulation of reactive oxygen species (ROS), cellular pyroptosis, and extracellular matrix (ECM) degradation. There are currently no approved specific molecular therapies for IVDD. In this study, we developed a multifunctional and microenvironment-responsive metal-phenolic network release platform, termed TMP@Alg-PBA/PVA, which could t  ...[more]

Similar Datasets

| S-EPMC7852332 | biostudies-literature
2024-04-05 | GSE230809 | GEO
| PRJNA962588 | ENA
| S-EPMC9251272 | biostudies-literature
| S-EPMC9863885 | biostudies-literature
| S-EPMC7295059 | biostudies-literature
| S-EPMC9399388 | biostudies-literature
| S-EPMC11493826 | biostudies-literature
| S-EPMC6223888 | biostudies-literature
| S-EPMC9036167 | biostudies-literature